1
Observational Study of a Novel Peri Infusion Regimen on the Infusion Associated Reactions With Alemtuzumab Infusion in Patients With Multiple Sclerosis in a Canadian Clinical Setting.
Condition(s):Frequency of Infusion Reactions in Novel Versus Standard Protocol in Multiple SclerosisLast Updated:March 13, 2024Completed